PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396 | -27.1% | 604,678 | +4.5% | 0.00% | 0.0% |
| Q2 2023 | $543 | -1.8% | 578,806 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $553 | -30.7% | 578,806 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $798 | -99.9% | 578,806 | +16.3% | 0.00% | +33.3% |
| Q3 2022 | $620,000 | -37.4% | 497,553 | +18.6% | 0.00% | -40.0% |
| Q2 2022 | $990,000 | +99.6% | 419,564 | +161.8% | 0.01% | +150.0% |
| Q1 2022 | $496,000 | – | 160,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
| BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
| Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
| Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
| Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
| Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
| Annandale Capital, LLC | 54,338 | $51 | 0.02% |